Kosj Yamoah
Chair, Department of Radiation Oncology · University of South Florida Morsani College of Medicine
Credentials: · · · · · ·
History
- Present
GME Program Administrator · University of South Florida Morsani College of Medicine
- Present
Department of Radiation Oncology · University of South Florida Morsani College of Medicine

- 2010–2011
Preliminary or Transitional Year
Research
Nedd8 on cullin: building an expressway to protein destruction
Review · Oncogene · 2004 · 367 citations
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 244 citations
Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species
The EMBO Journal · 2007 · 216 citations

20 papers · 20 as a resident

20 papers
- DG
18 papers · 2 as a resident
- JP
18 papers
- PJ
18 papers
- JT
17 papers

16 papers

14 papers · 5 as a resident
Grants
- 2022–2027
National Cancer Institute · R37
Contact PI · $3.3M · h. Lee Moffitt Cancer Ctr & Res Inst
- 2021–2027
Ghana IntegRative Approach to Cancer ResEarch Training: The Grace Program
National Cancer Institute · D43
Contact PI · $1.4M · h. Lee Moffitt Cancer Ctr & Res Inst
- 2022
Precision Interception of Aggressive Prostate Cancer in African American Men
National Cancer Institute · P20
Project lead · $641.2K · Dana-Farber Cancer Inst
Clinical trials
- 2019–2029
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores
Principal investigator · Recruiting · Phase 2, Phase 3
H. Lee Moffitt Cancer Center and Research Institute
- 2018–2026
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
Principal investigator · Completed · Phase 1, Phase 2
H. Lee Moffitt Cancer Center and Research Institute
- 2016–2026
Validation Study on the Impact of Decipher® Testing - VANDAAM Study
Principal investigator · Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
- 2020–2032
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group


